N1-Methyl-lysergic acid diethylamide

From WikiMD's Medical Encyclopedia


N1-Methyl-lysergic acid diethylamide[edit]

File:MLD-41.svg
Chemical structure of N1-Methyl-lysergic acid diethylamide

N1-Methyl-lysergic acid diethylamide (MLD-41) is a chemical compound that belongs to the ergoline family. It is a derivative of lysergic acid diethylamide (LSD), which is a well-known psychedelic drug. MLD-41 is characterized by the addition of a methyl group at the N1 position of the lysergic acid moiety.

Chemical Structure[edit]

MLD-41 shares a similar core structure with LSD, which is based on the ergoline skeleton. The primary difference between MLD-41 and LSD is the presence of a methyl group attached to the nitrogen atom at the N1 position. This modification can influence the compound's pharmacological properties and its interaction with serotonin receptors.

Pharmacology[edit]

MLD-41, like other ergoline derivatives, is believed to interact with various neurotransmitter systems in the brain, particularly the serotonin system. The addition of the methyl group may alter its binding affinity and efficacy at serotonin receptors, potentially leading to differences in its psychoactive effects compared to LSD.

Effects[edit]

The psychoactive effects of MLD-41 are not as well-documented as those of LSD. However, it is hypothesized that MLD-41 may produce similar hallucinogenic effects, including alterations in perception, mood, and cognition. The specific effects and potency of MLD-41 relative to LSD remain a subject of research.

Synthesis[edit]

The synthesis of MLD-41 involves the chemical modification of LSD. This process typically requires the introduction of a methyl group to the N1 position of the lysergic acid diethylamide molecule. The synthesis of such compounds is complex and requires expertise in organic chemistry.

Legal Status[edit]

The legal status of MLD-41 varies by country. In many jurisdictions, it may be classified under the same legal framework as LSD due to its structural similarity and potential for psychoactive effects. Researchers and chemists must be aware of the legal implications of working with such compounds.

Related Compounds[edit]

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=N1-Methyl-lysergic_acid_diethylamide&oldid=6299688"